Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_provenance.
- NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_assertion description "[It seems likely that the 307Ser variant of the CD226 receptor is associated with APS2 because of its underlying association with type 1 diabetes and autoimmune thyroid disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_provenance.
- NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_assertion evidence source_evidence_literature NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_provenance.
- NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_assertion SIO_000772 21521299 NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_provenance.
- NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_assertion wasDerivedFrom befree-20140225 NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_provenance.
- NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_assertion wasGeneratedBy ECO_0000203 NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP815616.RAuL8XwWHAH8cAhna-LN_sm_VeQlZI-gCtM_Nrui4T6oM130_provenance.